explore -WSS

explore

author：entertainment 2025-10-02 23:47:33 - browse：266

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Stanford updates investigation of president’s past research

Wikipedia

leisure time

WSS

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Eye stem cell transplant could help restore vision in injured people

Clinical trials must include more disabled people

Ukraine taking heavy casualties 10 weeks into its counteroffensive

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

knowledge

explore

Wikipedia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

As Maui death toll rises, number of missing remains unclear

DIEP, the 'gold standard' of breast reconstruction, is under threat

Why the Crimean Bridge is key to Russia's war in Ukraine

Alkermes shareholders re

Norman Reedus' Daryl Dixon

How one medical school became remarkably diverse

Eye stem cell transplant could help restore vision in injured people

DIEP, the 'gold standard' of breast reconstruction, is under threat

Patient advocates sound warning on FDA proposal on salt intake

explore

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

New definition of a human embryo proposed amid rapid advances

Why the Crimean Bridge is key to Russia's war in Ukraine

The boys, now 6, who are gene therapy’s ‘edge case’ problem

As Maui death toll rises, number of missing remains unclear

Liz Cheney makes 1st public comment since Trump's election interference indictments

Wikipedia

leisure time

hotspot

hotspot